VLY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
VLY is not a good immediate buy for a Beginner long-term investor with $50,000-$100,000 right now. The stock is in a short-term uptrend, but it is overbought, options sentiment is bearish, and there is no fresh news catalyst. If already owned, holding is reasonable; if not, I would wait for a pullback before entering.
Price is 14.575 and trading above the pivot (13.986) and both moving averages, with bullish alignment SMA_5 > SMA_20 > SMA_200. MACD histogram is positive and expanding, which supports upward momentum. However, RSI_6 is 82.962, which is deeply overbought and suggests the current move is stretched. Near-term resistance sits at 14.469 and 14.767, so upside from here looks limited without a consolidation first.
Hedge funds are reported buying strongly, which is a meaningful positive institutional signal. Analyst sentiment has improved overall over the last month, with multiple firms raising price targets after a Q1 EPS beat, stronger core deposit growth, stable NIM, and raised 2026 NII guidance. Technical momentum is also positive, with MACD expanding above zero and moving averages trending bullish.
No news in the recent week means there is no fresh event-driven catalyst. RSI is overbought, making the current entry less attractive. Congress trading shows 1 recent sale and 0 purchases, which is mildly negative. The stock trend model also points to weak short-term returns, including a -2.19% estimate over the next month.
Latest quarter season was 1Q 2026. The company reported an EPS beat, raised 2026 NII guidance, and showed strong core deposit growth, stable NIM trends, solid loan growth, and buybacks. Analyst commentary also pointed to improved profitability and a clearer path to earnings growth. Overall, the latest quarter shows improving operating momentum rather than deterioration.
Analyst trend is constructive but mixed. Several firms raised targets recently: TD Cowen to $17, Piper Sandler to $16, JPMorgan to $15, RBC to $16, and Truist to $14.50, reflecting better earnings and margin trends. The main negative change was Morgan Stanley downgrading the stock to Equal Weight from Overweight with a $15 target due to valuation after a strong run. Wall Street’s pros see better NIM, deposit growth, loan growth, and buybacks; the cons are that much of the improvement may already be priced in and some firms now view valuation as less attractive.
